Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seiler

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|June 1, 1986
Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituentsM P Seiler, A P Stoll, A Closse, et al.
American Journal of Respiratory Cell and Molecular Biology|August 2, 2002
Thixotropic solutions enhance viral-mediated gene transfer to airway epitheliaMichael P Seiler, Paul Luner, Thomas O Moninger, et al.
Plos Pathogens|June 5, 2010
Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferretsNatalia A Ilyushina, Jon P Seiler, Jerold E Rehg, et al.
Infection and Immunity|September 1, 1994
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathwayY Ma, K P Seiler, K F Tai, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureusA J Lepak, P Seiler, J P Surivet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibodyP Seiler, B M Senn, M A Bründler, et al.
Infection and Immunity|January 10, 1998
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N miceY Ma, K P Seiler, E J Eichwald, et al.
The Journal of Experimental Medicine|March 28, 1998
Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunizationP Seiler, M A Bründler, C Zimmermann, et al.
Infection and Immunity|November 14, 2001
Limited mycobacterial infection of the liver as a consequence of its microanatomical structure causing restriction of mycobacterial growth to professional phagocytesP Seiler, R A Schwendener, S Bandermann, et al.
Journal of Virology|March 14, 1998
Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic miceP Seiler, U Kalinke, T Rülicke, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|June 1, 1986
Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituentsM P Seiler, A P Stoll, A Closse, et al.
American Journal of Respiratory Cell and Molecular Biology|August 2, 2002
Thixotropic solutions enhance viral-mediated gene transfer to airway epitheliaMichael P Seiler, Paul Luner, Thomas O Moninger, et al.
Plos Pathogens|June 5, 2010
Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferretsNatalia A Ilyushina, Jon P Seiler, Jerold E Rehg, et al.
Infection and Immunity|September 1, 1994
Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathwayY Ma, K P Seiler, K F Tai, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2016
In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureusA J Lepak, P Seiler, J P Surivet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 14, 1999
In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibodyP Seiler, B M Senn, M A Bründler, et al.
Infection and Immunity|January 10, 1998
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N miceY Ma, K P Seiler, E J Eichwald, et al.
The Journal of Experimental Medicine|March 28, 1998
Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunizationP Seiler, M A Bründler, C Zimmermann, et al.
Infection and Immunity|November 14, 2001
Limited mycobacterial infection of the liver as a consequence of its microanatomical structure causing restriction of mycobacterial growth to professional phagocytesP Seiler, R A Schwendener, S Bandermann, et al.
Journal of Virology|March 14, 1998
Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic miceP Seiler, U Kalinke, T Rülicke, et al.
Pageof 12